Verum Partners LLC

Position in MRK — Merck & Co., Inc.

CIK 1958984 CHARLOTTE, NC

Position in MRK

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$739,903

+$223,980 QoQ

Shares Held

5,758

+34.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.66%

of 13F equity value

Holder Rank

#2,365

of 3,769 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Verum Partners LLC holds $8,397,946 across 6 Drug Manufacturers - General names. MRK ranks #4 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,715	$4,455,882
2	JNJ	Johnson & Johnson	6,156	$1,563,439
3	ABBV	AbbVie Inc.	3,851	$969,065
4	MRK	Merck & Co., Inc. This page	5,758	$739,903
5	AMGN	Amgen Inc	1,290	$467,134
6	GILD	Gilead Sciences, Inc.	1,603	$202,523

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$739,903	5,758	+34.3%	Shares	Sole	2026-07-22
2026-03-31	$515,923	4,289	+12.5%	Shares	Sole	2026-04-15
2025-12-31	$401,251	3,812	+15.1%	Shares	Sole	2026-01-14
2025-09-30	$277,976	3,312	-6.7%	Shares	Sole	2025-11-12
2025-06-30	$281,018	3,550	+8.3%	Shares	Sole	2025-07-15
2025-03-31	$294,233	3,278	-3.2%	Shares	Sole	2025-04-11
2024-12-31	$336,938	3,387	+0.3%	Shares	Sole	2025-01-17
2024-09-30	$383,605	3,378	-1.8%	Shares	Sole	2024-10-16
2024-06-30	$425,872	3,440	-0.7%	Shares	Sole	2024-07-15
2024-03-31	$457,074	3,464	+13.6%	Shares	Sole	2024-04-18
2023-12-31	$332,292	3,048	-8.7%	Shares	Sole	2024-01-18
2023-09-30	$343,853	3,340	+52.8%	Shares	Sole	2023-10-10
2023-03-31	$232,568	2,186	+4.9%	Shares	Sole	2023-04-13
2022-12-31	$231,108	2,083	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.